Your session is about to expire
← Back to Search
Probiotic
Culturelle probiotic for Clostridium Difficile Diarrhea
N/A
Waitlist Available
Led By Linda Adams, RPh
Research Sponsored by St. Vincent's East, Birmingham, Alabama
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to six months
Awards & highlights
Study Summary
We have designed this study to measure the effect of normal flora supplementation, using available probiotics, on the incidence of Clostridium difficile-associated diarrhea in a population of general inpatients who are receiving antibiotics.
Eligible Conditions
- Clostridium Difficile Diarrhea
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to six months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to six months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Development of Clostridium difficile associated diarrhea in patients receiving antibiotics
Trial Design
3Treatment groups
Active Control
Placebo Group
Group I: Culturelle probioticActive Control1 Intervention
Group II: Theralac probioticActive Control1 Intervention
Group III: PlaceboPlacebo Group1 Intervention
Find a Location
Who is running the clinical trial?
St. Vincent's East, Birmingham, AlabamaLead Sponsor
Master Supplements, IncOTHER
Linda Adams, RPhPrincipal InvestigatorSt. Vincent's East
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger